|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011209,
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0079809,
umls-concept:C0220931,
umls-concept:C0332307,
umls-concept:C0795635,
umls-concept:C0991575,
umls-concept:C1442989,
umls-concept:C1707455
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-2-23
|
|
pubmed:abstractText |
The Lilly/Alkermes human insulin inhalation powder (HIIP) delivery system [AIR (a registered trademark of Alkermes, Inc., Cambridge, MA) Inhaled Insulin System] was designed to be easy to use. Training methods were compared in insulin-naive patients with type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1520-9156
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
80-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17316102-Administration, Inhalation,
pubmed-meshheading:17316102-Aged,
pubmed-meshheading:17316102-Body Weight,
pubmed-meshheading:17316102-Diabetes Mellitus, Type 2,
pubmed-meshheading:17316102-Female,
pubmed-meshheading:17316102-Humans,
pubmed-meshheading:17316102-Hypoglycemia,
pubmed-meshheading:17316102-Hypoglycemic Agents,
pubmed-meshheading:17316102-Insulin,
pubmed-meshheading:17316102-Male,
pubmed-meshheading:17316102-Middle Aged,
pubmed-meshheading:17316102-Patient Education as Topic,
pubmed-meshheading:17316102-Radiography, Thoracic,
pubmed-meshheading:17316102-Random Allocation,
pubmed-meshheading:17316102-Respiratory Function Tests,
pubmed-meshheading:17316102-Single-Blind Method,
pubmed-meshheading:17316102-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures.
|
|
pubmed:affiliation |
Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas 75230, USA. juliorosenstock@dallasdiabetes.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
